Yüklüyor......
Pathological findings in Central Nervous System Demyelination associated with Infliximab
BACKGROUND: Tumor Necrosis Factor alpha (TNF-alpha) inhibitors, such as infliximab, are commonly used to treat rheumatoid arthritis (RA) and other immune-mediated disorders. OBJECTIVE: To determine whether infliximab-associated CNS demyelination can be differentiated from MS. METHODS: We present a c...
Kaydedildi:
| Yayımlandı: | Mult Scler |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7297659/ https://ncbi.nlm.nih.gov/pubmed/31845616 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458519894710 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|